Dianthus Therapeutics, Inc. (DNTH) Forecast: Analyst Ratings & Targets

Latest DNTH Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Date	Analyst	Firm	Action	Rating	Price Target
Mar 19, 2026	Sadia Rahman	Wells Fargo	Initiates	Buy	$135.00
Mar 12, 2026	Laura Chico	Wedbush	Maintains	Buy	$80.00 → $103.00 +23.00 (28.8%)
Mar 10, 2026	Bill Maughan	Clear Street	Maintains	Strong Buy	$100.00 → $130.00 +30.00 (30.0%)
Mar 10, 2026	Laura Chico	Wedbush	Maintains	Buy	$55.00 → $80.00 +25.00 (45.5%)
Mar 10, 2026	Joel Beatty	Baird	Maintains	Buy	$67.00 → $132.00 +65.00 (97.0%)
Mar 10, 2026	Steven Seedhouse	Raymond James	Upgrades	Strong Buy	$63.00 → $123.00 +60.00 (95.2%)
Mar 9, 2026	Swayampakula Ramakanth	HC Wainwright	Maintains	Strong Buy	$47.00 → $130.00 +83.00 (176.6%)
Mar 9, 2026	Danielle Brill	Truist	Maintains	Strong Buy	$63.00 → $110.00 +47.00 (74.6%)
Mar 9, 2026	Leland Gershell	Oppenheimer	Maintains	Buy	$125.00 → $145.00 +20.00 (16.0%)
Mar 4, 2026	Yatin Suneja	Guggenheim	Maintains	Strong Buy	$100.00 → $200.00 +100.00 (100.0%)
Feb 11, 2026	Laura Chico	Wedbush	Maintains	Buy	$46.00 → $55.00 +9.00 (19.6%)
Feb 2, 2026	Maury Raycroft	Jefferies	Maintains	Strong Buy	$66.00 → $81.00 +15.00 (22.7%)
Jan 8, 2026	Danielle Brill	Truist	Maintains	Strong Buy	$56.00 → $63.00 +7.00 (12.5%)

Sadia Rahman

Wells Fargo

BuyInitiates

$135.00

Mar 19

Laura Chico

Wedbush

BuyMaintains

$80.00 → $103.00

Mar 12

Bill Maughan

Clear Street

Strong BuyMaintains

$100.00 → $130.00

Mar 10

Laura Chico

Wedbush

BuyMaintains

$55.00 → $80.00

Mar 10

Joel Beatty

Baird

BuyMaintains

$67.00 → $132.00

Mar 10

Steven Seedhouse

Raymond James

Strong BuyUpgrades

$63.00 → $123.00

Mar 10

Swayampakula Ramakanth

HC Wainwright

Strong BuyMaintains

$47.00 → $130.00

Mar 9

Danielle Brill

Truist

Strong BuyMaintains

$63.00 → $110.00

Mar 9

Leland Gershell

Oppenheimer

BuyMaintains

$125.00 → $145.00

Mar 9

Yatin Suneja

Guggenheim

Strong BuyMaintains

$100.00 → $200.00

Mar 4

Laura Chico

Wedbush

BuyMaintains

$46.00 → $55.00

Feb 11

Maury Raycroft

Jefferies

Strong BuyMaintains

$66.00 → $81.00

Feb 2

Danielle Brill

Truist

Strong BuyMaintains

$56.00 → $63.00

Jan 8

Frequently Asked Questions

What is the analyst consensus rating for DNTH?

The analyst consensus rating for DNTH is "Strong Buy" based on 10 analyst recommendations.

What is the average price target for DNTH?

The average 12-month price target for DNTH is $128.90, representing an upside of 49.9% from the current price of $86.00.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.

Dianthus Therapeutics, Inc. (DNTH) Analyst Forecast

Analyst Consensus Rating

Consensus Rating

Average Price Target

Latest DNTH Analyst Ratings & Recommendations

Frequently Asked Questions